Where does Juno Therapeutics, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Juno Therapeutics, Inc. ranks #5,295 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Juno Therapeutics, Inc. hold?

Juno Therapeutics, Inc. holds 65 US utility patents granted between 2019 and 2025, spanning 16 technology areas.

What is Juno Therapeutics, Inc.'s Innovation Score?

Juno Therapeutics, Inc. has an Innovation Score of 63.6 out of 100 (top 2% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Juno Therapeutics, Inc.'s patent grant rate increasing or decreasing?

Juno Therapeutics, Inc.'s recent grant velocity is +1125% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Juno Therapeutics, Inc.'s patents?

Juno Therapeutics, Inc.'s patents average 32.5 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Juno Therapeutics, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Juno Therapeutics, Inc.

Q: What technology areas does Juno Therapeutics, Inc. focus on?

Juno Therapeutics, Inc.'s top technology area is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes) with 56 patents. Grants appear in 16 CPC subclasses total.

USPTO PatentsView assignee record - 65 granted patents across 16 technology areas, recorded in grant years 2019–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61K (Preparations FOR Medical, Dental OR Toiletry Purposes).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Juno ranks #5,295 of 49,997 tracked US assignees by granted-patent volume, with 65 patents across 16 technology areas.

#5,295
of 49,997 US assignees by volume: Top 2%
by Innovation Score (63.6/100): 32.5
avg claims per patent: +1125%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R5295 · US Corporation #5,295 · 65 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-STRONG · CLAIMS-DENSE · TYPE-USCORP · VEL-SURGE · BOOK-FULL

GRANTS-SMALL 65 grants
UPPER-Q #5,295/49,997
PHOTO-FINISH Inari Medical
CPC-FOCUS A61K · 16 areas
INNOV-STRONG 63.6/100
CLAIMS-DENSE 32.5 claims/avg
TYPE-USCORP US Corporation
VEL-SURGE +1125% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Inari Medical, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Qualcomm Incorporated · highest

85
Schreder · near

64
GlobalFoundries… · near

64
Juno Therapeutics · this assignee

64
Avery Dennison · near

64
Yeda Research AND… · near

64
3D Lighting… · lowest

7

What this shows Juno's Innovation Score is 63.6/100 (top 2% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Where Juno's grants concentrate

Juno Therapeutics, Inc. is a focused PatentsView assignee: 16 CPC subclasses with 86.2% of grants classified under A61K (Preparations FOR Medical, Dental OR Toiletry Purposes). Peak complete grant year is 2024 (17 grants) versus a trough of 3 in 2020. By volume, Juno sits between Inari Medical, Inc. and Liebherr-verzahntechnik GMBH.

Juno's three-year grant acceleration

Juno Therapeutics, Inc. shows 42 grants in 2022–2024 against only 11 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Inari Medical

65
Inventec Applianc…

65
Jusung Engineering

65
Johnstech Interna…

65
Kinaxis

65
Konkuk University…

65
Kunming Universit…

65
Liebherr-verzahnt…

65
Juno Therapeutics ◀

65

What this shows Juno holds 65 patents at rank #5,295, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Juno

By rank, the assignees closest to #5,295 in granted patent volume.

Leaders in A61K (Preparations FOR Medical)

Other assignees with the most granted patents in Juno's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Juno, neither rank-band nor same-CPC leaders (those blocks stay above).

Similar innovation score

Nearest assignees by Innovation Score (64 here).

GlobalFoundries Singapore Pte. Ltd. 64 Schreder S.A. 64 Avery Dennison Corporation 64 Yeda Research AND Development Co. Ltd. 64

Similar claim depth

Nearest assignees by average claims per patent (32.5 here).

Berkshire Grey Operating Company, Inc. 32.5 avg Elwha LLC 32.6 avg Lantech.com, LLC 32.7 avg FireEye, Inc. 32.3 avg

Juno's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

64 Top 2% higher than 98% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2019–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2019–2019 baseline. Full figures in the table below.

View data table

Juno Therapeutics, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2019	4	6.2%
2020	3	4.6%
2021	4	6.2%
2022	11	16.9%
2023	14	21.5%
2024	17	26.2%
2025partial year	12	18.5%

Which technologies does Juno Therapeutics, Inc. patent most?

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 56

C07K - Peptides 52

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 43

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 39

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 23

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 10

C12Y - Enzymes 5

C12M - Apparatus FOR Enzymology OR MICROBIOLOGY; Apparatus FOR Culturing Microorganisms FOR Producing Biomass, FOR Growing Cells OR FOR Obtaining Fermentation OR Metabolic Products, i.e. Bioreactors OR Fermenters 5

B01D - Separation 3

Y02P - Climate Change Mitigation Technologies IN THE Production OR Processing OF Goods 3

B65D - Containers FOR Storage OR Transport OF Articles OR Materials, e.g. Bags, Barrels, Bottles, Boxes, Cans, Cartons, Crates, Drums, Jars, Tanks, Hoppers, Forwarding CONTAINERS; Accessories, Closures, OR Fittings THEREFOR; Packaging ELEMENTS; Packages 2

B04B - Centrifuges 2

Y02A - Technologies FOR Adaptation TO Climate Change 1

A61J - Containers Specially Adapted FOR Medical OR Pharmaceutical PURPOSES; Devices OR Methods Specially Adapted FOR Bringing Pharmaceutical Products Into Particular Physical OR Administering FORMS; Devices FOR Administering Food OR Medicines ORALLY; Baby COMFORTERS; Devices FOR Receiving Spittle 1

G16B - Bioinformatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR Genetic OR Protein-related Data Processing IN Computational Molecular Biology 1

Top 15 of 16 technology areas

Where it ranks

Overall rank by patents

#5,295

of 49,997 tracked assignees

Innovation Score

63.6 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Juno Therapeutics, Inc.'s patent record in context - here's where to go next.

Juno Therapeutics, Inc.'s lead technology class is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes), 86.2% of its portfolio - see every assignee active in that class. Explore A61K
Ranked #5,295 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Juno Therapeutics, Inc. against Inari Medical, Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 63.6/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.